Praptihinge (1)

1

• Contraceptive Drugs Market Size, Share, Research
  Scope and Recent Industry Developments Bayer,
  Pfizer and more Forecast till 2025
• In a report, titled Contraceptive Drugs Market-
  Global Market Analysis, Insights, and Forecasts,
  2018 2025, Fortune Business Insights predicts
  the market to reach a value of US 20,200.5 Mn
  by the end of 2025. The earlier records of 2017
  market share states the revenue to be
  US13,097.7 Mn, implying a remarkable growth rate
  in the coming years with a CAGR of 5.8.
• The rising prevalence of unwanted pregnancies is
  boosting the global contraceptive drugs market.
  In a report, titled Contraceptive Drugs Market
  Size, Share and Global Trend by Product Type
  (Oral, Injectable, Patches), Distribution Channel
  (Hospital Pharmacy, Retail Pharmacy, Clinics,
  Online Channel, Public Channel NGOs) and
  Geography Forecast till 2025 Fortune Business
  Insights identifies various factors enabling
  growth in the market.
• According to the report, the global contraceptive
  drugs market is anticipated to rise at 5.8 CAGR
  and reach a value of US 20,200.5 Mn by 2025 from
  US 13,097.7 Mn in 2017. Remarkably improving
  access to contraceptive pills around the world is
  a key factor propelling growth in this market.
• Sample PDF Brochure https//www.fortunebusinessins
  ights.com/enquiry/request- sample-pdf/contracepti
  ve-drugs-market-100063
• Top Players Overview
• Some of the leading companies that are operating
  in the global Contraceptive Drugs Market are
• Bayer
• Pfizer
• The Janssen Pharmaceutical Companies, LLC
• Teva Pharmaceuticals
• Merck
• Mylan N.V.
• Allergan Plc

2
As per the World Health Organization, there is an
estimated 40 to 50 million abortions every year,
corresponding to an approximate of 125,000
abortions per day. To avoid unwanted and
unplanned pregnancies, an increasing number of
women are opting for contraceptive drugs. This
will, in turn, augment growth in the global
market. Contrary to this, the market for
contraceptive drugs may face challenges posed by
religious, ethical, and social barriers,
especially in more conservative regions. Social
taboos often discourage the use of contraceptive
drugs among women, subsequently adversely
impacting the overall market. Nevertheless,
evolving lifestyle and rising awareness are
enabling women to mitigate aforementioned
concerns, in turn supporting the expansion of the
contraceptive drugs market. This, coupled with,
government initiatives to create awareness around
the world is expected to boost the global market
in the coming years. Government Initiatives to
Promote Use of Contraceptive Medicines Geographic
ally, North America held dominance in the global
contraceptive drugs market owing to the presence
of leading players in the region. This,
accompanied with easy availability of
contraceptive drugs, has catapulted North America
to the fore of the global market. However, Asia
Pacific is most likely to emerge as the fastest
growing region. This is owing to government
initiatives adopted across emerging nations of
this region. These initiatives are intended at
promoting the use of contraceptive medicines as a
convenient way of preventing unwanted
pregnancy. According to Fortune Business
Insights, the global contraceptive drugs market
has a highly fragmented vendor landscape. This
is because of the presence of both regional and
international players. Major players are focusing
on expanding their footprint across the world to
gain a strong foothold in the market. Manufacture
rs are also putting efforts to improve their
product visibility especially in developing
economies with new marketing strategies. This is
likely to make the competition fiercer as
manufacturers are investing huge sums into
research and development. Some of the players
operating in the global contraceptive drugs
market are Agile Therapeutics, Teva
Pharmaceuticals Industry, Bayer AG, Mylan, Lupin
Pharmaceuticals Ltd, Janssen Pharmaceutical
Company, and Novartis AG. Browse Complete Report
Details at https//www.fortunebusinessinsights.com
/industry- reports/contraceptive-drugs-market-100
063